A prediction model for duration of sickness absence due to stress-related disorders.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 24 10 2018
revised: 15 01 2019
accepted: 22 01 2019
pubmed: 3 3 2019
medline: 11 7 2019
entrez: 3 3 2019
Statut: ppublish

Résumé

Stress-related disorders are leading causes of long-term sickness absence (SA) and there is a great need for decision support tools to identify patients with a high risk for long-term SA due to them. To develop a clinically implementable prediction model for the duration of SA due to stress-related disorders. All new SA spells with F43 diagnosis code lasting >14 days and initiated between 2010-01-01 and 2012-06-30 were identified through data from the Social Insurance Agency. Information on baseline predictors was linked on individual level from other nationwide registers. Piecewise-constant hazard regression was used to predict the duration of the SA. Split-sample validation was used to develop and validate the model, and c-statistics and calibration plots to evaluate it. Overall 83,443 SA spells, belonging to 77,173 individuals were identified. The median SA duration was 55 days (10% were >365 days). Age, sex, geographical region, employment status, educational level, extent of SA at start and SA days, outpatient healthcare visits, and multi-morbidity in the preceding 365 days were selected to the final model. The model was well calibrated. The overall c-statistics was 0.54 (95% confidence intervals: 0.53-0.54) and 0.70 (95% confidence intervals: 0.69-0.71) for predicting SA spells >365 days. The heterogeneity of the F43-diagnosis and the exclusive use of register-based predictors limited our possibility to increase the discriminatory accuracy of the prediction. The final model could be implementable in clinical settings to predict duration of SA due to stress-related disorders and could satisfyingly discriminate long-term SA.

Sections du résumé

BACKGROUND
Stress-related disorders are leading causes of long-term sickness absence (SA) and there is a great need for decision support tools to identify patients with a high risk for long-term SA due to them.
AIMS
To develop a clinically implementable prediction model for the duration of SA due to stress-related disorders.
METHODS
All new SA spells with F43 diagnosis code lasting >14 days and initiated between 2010-01-01 and 2012-06-30 were identified through data from the Social Insurance Agency. Information on baseline predictors was linked on individual level from other nationwide registers. Piecewise-constant hazard regression was used to predict the duration of the SA. Split-sample validation was used to develop and validate the model, and c-statistics and calibration plots to evaluate it.
RESULTS
Overall 83,443 SA spells, belonging to 77,173 individuals were identified. The median SA duration was 55 days (10% were >365 days). Age, sex, geographical region, employment status, educational level, extent of SA at start and SA days, outpatient healthcare visits, and multi-morbidity in the preceding 365 days were selected to the final model. The model was well calibrated. The overall c-statistics was 0.54 (95% confidence intervals: 0.53-0.54) and 0.70 (95% confidence intervals: 0.69-0.71) for predicting SA spells >365 days.
LIMITATIONS
The heterogeneity of the F43-diagnosis and the exclusive use of register-based predictors limited our possibility to increase the discriminatory accuracy of the prediction.
CONCLUSION
The final model could be implementable in clinical settings to predict duration of SA due to stress-related disorders and could satisfyingly discriminate long-term SA.

Identifiants

pubmed: 30825717
pii: S0165-0327(18)32485-6
doi: 10.1016/j.jad.2019.01.045
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-15

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Katalin Gémes (K)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Paolo Frumento (P)

Unit of Biostatistics, Department of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.

Gino Almondo (G)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Matteo Bottai (M)

Unit of Biostatistics, Department of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.

Johanna Holm (J)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Kristina Alexanderson (K)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: kristina.alexanderson@ki.se.

Emilie Friberg (E)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: emilie.friberg@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH